A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin’s Lymphoma
 
Sponsors and Collaborators
Ohio State University Comprehensive Cancer Center
Celgene Corporation
Novartis
 
Contact
Ohio State University Comprehensive Cancer Center
1-800-293-5066
 
Kristie Blum, MD
614-293-4590
 
Investigator
Kristie Blum, MD
The Ohio State University Medical Center
 
ClinicalTrials.gov Identifier